Not only is December ASH month, but in my family, it is also birthday month! I turned 59 a week ago, and two of my four children also have December birthdays. As a matter of fact, today my younger...
Reasons to Celebrate
read more
Jill Zitzewitz, PhD
Jill Zitzewitz, PhD is an associate professor in academic medicine. She spent her career studying therapeutic development for protein misfolding diseases. Since being diagnosed with multiple myeloma in 2017, Jill has been teaching full–time while providing a patient’s perspective through her experiences with multiple myeloma. Current myeloma therapies have allowed her to continue teaching and to be a mother to four young adults. In 2020, Jill became the leader for the central MA multiple myeloma support group of the IMF. This is the first time that Jill will be attending the ASH Conference as a patient advocate rather than as a scientific researcher. She plans to use her background in science and education to help patients understand the important impact of new and novel therapies for treating multiple myeloma.
Follow Jill on Twitter: @JillZitzewitz
Support Group Website: Central MA Multiple Myeloma Support Group
The Myeloma Treatment Landscape
The very first session I attended at this year’s American Society of Hematology (ASH) Annual Meeting was a Friday Satellite Symposium sponsored by Clinical Care Options and the International Myeloma...
The Promise of Research
Hello from central Massachusetts! I am so excited for the opportunity to attend the 64th American Society of Hematology Annual Meeting and Exposition (ASH). This will be my second year at ASH, where...